Target Name: ARMH1
NCBI ID: G339541
Review Report on ARMH1 Target / Biomarker Content of Review Report on ARMH1 Target / Biomarker
ARMH1
Other Name(s): Armadillo-like helical domain containing protein 1 | P40 | Armadillo like helical domain containing 1 | armadillo like helical domain containing 1 | MGC33556 | uncharacterized protein C1orf228 | ARMD1_HUMAN | C1orf228 | p40 | NCRNA00082

Unlock The Potential of ARMH1: A Protein with Unique Helical Structure

ARMH1, also known as Armadillo-like helical domain containing protein 1, is a protein that is found in a wide range of organisms, including humans. It is made up of 251 amino acids and has a unique structure that is similar to that of armadillos, which are known for their ability to walk on their stomachs.

One of the unique features of ARMH1 is its ability to form a helical structure, which is a type of protein that can twist and turn in a specific way to catch and store information. This ability is thought to be the reason why ARMH1 has been shown to play a role in a wide range of biological processes, including cell signaling, DNA replication, and metabolism.

In addition to its unique structure and its ability to form a helical structure, ARMH1 has also been shown to have a number of different functions in the cell. For example, it has been shown to play a role in the regulation of gene expression, which is the process by which a cell's DNA is used to create the proteins that are needed to carry out its functions.

In addition to its functions in the cell, ARMH1 has also been shown to be a potential drug target. This is because of its unique structure and its ability to form a helical structure, which makes it an attractive target for drug developers.

One of the specific ways that ARMH1 could be used as a drug target is by targeting the armadillo-like domains that are present in the protein. These domains are thought to be the key to the protein's unique structure and its ability to form a helical structure, and targeting them could potentially lead to the development of new treatments for a wide range of diseases.

Another potential way that ARMH1 could be used as a drug target is by targeting the regions of the protein that are involved in its functions in the cell. For example, ARMH1 has been shown to play a role in the regulation of gene expression, which is the process by which a cell's DNA is used to create the proteins that are needed to carry out its functions. Targeting the regions of the protein that are involved in this function could potentially lead to the development of new treatments for a wide range of diseases.

In addition to its potential as a drug target, ARMH1 has also been shown to have a number of potential applications in a wide range of fields. For example, it has been shown to be involved in the regulation of the immune system, which is the body's system for fighting off infection and disease. This suggests that ARMH1 could potentially be used as an immune system stimulator, which could have a wide range of potential applications in the treatment of a wide range of diseases.

Overall, ARMH1 is a protein that is thought to be involved in a wide range of biological processes, including cell signaling, DNA replication, and metabolism. Its unique structure, including its ability to form a helical structure, makes it an attractive target for drug developers, and its functions in the cell, including its role in the regulation of gene expression, could also have a number of potential applications in the treatment of a wide range of diseases.

Protein Name: Armadillo Like Helical Domain Containing 1

The "ARMH1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARMH1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ARMH2 | ARMH3 | ARMH4 | ARMS2 | ARMT1 | ARNT | ARNT2 | ARNT2-DT | ARPC1A | ARPC1B | ARPC2 | ARPC3 | ARPC3P2 | ARPC3P5 | ARPC4 | ARPC4-TTLL3 | ARPC5 | ARPC5L | ARPIN | ARPIN-AP3S2 | ARPP19 | ARPP21 | ARR3 | ARRB1 | ARRB2 | ARRDC1 | ARRDC1-AS1 | ARRDC2 | ARRDC3 | ARRDC3-AS1 | ARRDC4 | ARRDC5 | Arrestin | ARSA | ARSB | ARSD | ARSF | ARSG | ARSH | ARSI | ARSJ | ARSK | ARSL | ART1 | ART3 | ART4 | ART5 | ARTN | ARV1 | ARVCF | ARX | Arylsulfatase | AS3MT | ASAH1 | ASAH1-AS1 | ASAH2 | ASAH2B | ASAP1 | ASAP1-IT1 | ASAP1-IT2 | ASAP2 | ASAP3 | ASB1 | ASB10 | ASB11 | ASB12 | ASB13 | ASB14 | ASB15 | ASB16 | ASB16-AS1 | ASB17 | ASB18 | ASB2 | ASB3 | ASB4 | ASB5 | ASB6 | ASB7 | ASB8 | ASB9 | ASB9P1 | ASCC1 | ASCC2 | ASCC3 | ASCL1 | ASCL3 | ASCL4 | ASCL5 | ASF1A | ASF1B | ASGR1 | ASGR2 | ASH1L | ASH1L-AS1 | ASH2L | Asialoglycoprotein receptor | Asialoglycoprotein Receptor (ASGPR) | ASIC1 | ASIC2